Polo-like kinase 1 (PLK1) signaling in cancer and beyond - ScienceDirect
Structural basis for the inhibition of Polo-like kinase 1 | Nature Structural & Molecular Biology
Development of Bifunctional Inhibitors of Polo‐Like Kinase 1 with Low‐Nanomolar Activities Against the Polo‐Box Domain - Scharow - 2016 - ChemBioChem - Wiley Online Library
Inhibition of polo-like kinase 1 (PLK1) facilitates reactivation of gamma-herpesviruses and their elimination | PLOS Pathogens
Frontiers | A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of Rhabdomyosarcomas
PLK-1 Inhibitors: New Treatment for MDS? - ppt download
Figure 2 from Polo-like kinase (PLK) inhibitors in preclinical and early clinical development in oncology. | Semantic Scholar
Polo-like kinases: conservation and divergence in their functions and regulation | Nature Reviews Molecular Cell Biology
Regulating a key mitotic regulator, polo‐like kinase 1 (PLK1) - Colicino - 2018 - Cytoskeleton - Wiley Online Library
Polo-like kinase 1 (PLK1) signaling in cancer and beyond - ScienceDirect
Mitotic Roles of Polo Like Kinase
Functional Dynamics of Polo-Like Kinase 1 at the Centrosome | Molecular and Cellular Biology
Polo Like Kinase-enzyme | Sino Biological
Polo-like Kinase 1 Licenses CENP-A Deposition at Centromeres - ScienceDirect
Switching Polo-like kinase-1 on and off in time and space: Trends in Biochemical Sciences
![PDF] Polo-like kinase 1: target and regulator of anaphase-promoting complex/cyclosome-dependent proteolysis. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1fab03d33f093b807e4c4dea23eab368e3b4ae0c/3-Figure1-1.png "PDF] Polo-like kinase 1: target and regulator of anaphase-promoting complex/cyclosome-dependent proteolysis. | Semantic Scholar")
PDF] Polo-like kinase 1: target and regulator of anaphase-promoting complex/cyclosome-dependent proteolysis. | Semantic Scholar
![The Polo-like kinase 1 inhibitor onvansertib represents a relevant treatment for head and neck squamous cell carcinoma resistant to cisplatin and radiotherapy [Abstract]](https://www.thno.org/v11/p9571/toc.jpg "The Polo-like kinase 1 inhibitor onvansertib represents a relevant treatment for head and neck squamous cell carcinoma resistant to cisplatin and radiotherapy [Abstract]")
The Polo-like kinase 1 inhibitor onvansertib represents a relevant treatment for head and neck squamous cell carcinoma resistant to cisplatin and radiotherapy [Abstract]
![PDF] The role of polo-like kinase 1 in carcinogenesis: cause or consequence? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/33119311272773173c201b3d02ff3ad18b4a1955/2-Figure1-1.png "PDF] The role of polo-like kinase 1 in carcinogenesis: cause or consequence? | Semantic Scholar")
PDF] The role of polo-like kinase 1 in carcinogenesis: cause or consequence? | Semantic Scholar
Polo-like Kinase 1 Inhibitors in Human Cancer Therapy: Development and Therapeutic Potential | Journal of Medicinal Chemistry
Polo-like Kinase 1 Inhibitors in Human Cancer Therapy: Development and Therapeutic Potential | Journal of Medicinal Chemistry
PLK1 - Wikipedia
Continuous polo-like kinase 1 activity regulates diffusion to maintain centrosome self-organization during mitosis | PNAS
Role of polo-like kinase 1 (PLK1) overexpression in cancer. In addition... | Download Scientific Diagram
Polo-like kinases: structural variations lead to multiple functions | Nature Reviews Molecular Cell Biology
